Comparative risk of failure of ABC/3TC or TDF/FTC based first-line regimens in patients with a high viral load-Reference-Cited by-同舟云学术

Comparative risk of failure of ABC/3TC or TDF/FTC based first-line regimens in patients with a high viral load

Published:2015-08-26 Issue:5 Volume:17 Page:380-384
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Flandre P¹²,Pugliese P³,Allavena C⁴,Katlama C⁵⁶,Cotte L⁷⁸,Cheret A⁹¹⁰,Cabié A¹¹¹²,Rey D¹³,Chirouze C¹⁴¹⁵,Bani-Sadr F¹⁶¹⁷,Cuzin L¹⁸,

Affiliation:

1. INSERM; UMR-S 1136; Paris France

2. Pierre Louis Institute of Epidemiology and Public Health; Sorbonne Universities, UPMC Université de Paris 06; Paris France

3. Infectious Diseases Department; CHU Archet; Nice France

4. Infectious Diseases Department; CHU Hotel Dieu; Nantes France

5. Pierre Louis Institute of Epidemiology and Public Health; Sorbonne University, UPMC Université de Paris 06, UMR_S 1136; Paris France

6. AP-HP; Groupe hospitalier Pitié Salpêtrière; Service des Maladies Infectieuses; Paris France

7. Infectious Diseases Department; Hospices Civils de Lyon; Lyon France

8. INSERM U1052; Lyon France

9. EA 3620; Université Paris-Descartes; Sorbonne Paris Cité; Paris France

10. Infectious Diseases Department; Tourcoing Genral Hospital; Tourcoing France

11. Infectious Diseases Department; CHU de Martinique; Fort de France France

12. Université Antilles Guyane EA 4537; CHU de Martinique; Pointe à Pitre France

13. Le Trait d'Union; HIV Care Center; CHU Strasbourg; Strasbourg France

14. UMR CNRS 6249 Chrono-Environnement; Université de Franche-Comté; CHRU Besançon; Besançon France

15. Service de maladies infectieuses; CHRU Besançon; Besançon France

16. Reims Champagne-Ardenne University; Faculté de médecine, EA-4684/SFR CAP-SANTE; Reims France

17. Tropical and Infectious Diseases; CHU Reims; Hôpital Robert Debré; Reims France

18. Regional Center for HIV Care and Coordination; INSERM UMR1027, Toulouse 3 University; Toulouse France

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference18 articles.

1. Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy;Sax;N Engl J Med,2009

2. Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment;Smith;AIDS,2009

3. Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1A randomized trial;Daar;Ann Intern Med,2011

4. Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study;Post;J Acquir Immune Defic Syndr,2010

5. Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Department of Health and Human Services http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents;Open Forum Infectious Diseases;2021-07-09

2. Organotin Polymers as Antiviral Agents Including Inhibition of Zika and Vaccinia Viruses;Journal of Inorganic and Organometallic Polymers and Materials;2019-07-05

3. Cascade of care and factors associated with virological suppression among HIV-positive persons linked to care in the Test and Keep in Care (TAK) project;Infection;2018-05-21

4. Candidates for inclusion in a universal antiretroviral regimen;Current Opinion in HIV and AIDS;2017-07